Voyager Therapeutics (VYGR) Enters Capsid License Agreement and Strategic Collaboration with Novartis to Advance Novel Gene Therapies streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Novartis, Voyager Ink Up-to-$1 3B Expansion of Neuro Gene Therapy Collaboration genengnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from genengnews.com Daily Mail and Mail on Sunday newspapers.
Voyager Therapeutics Inc. and Novartis AG signed a licensing agreement to develop treatments for neurological diseases. Shares of Voyager rose after the deal's announcement.
Novartis is paying Voyager Therapeutics $100 million up front to collaborate on gene therapies for Huntington’s disease and spinal muscular atrophy. The deal builds on a relationship the companies started in 2022.
Jay Bradner returns to lead R&D at Amgen—Chutes & Ladders fiercebiotech.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fiercebiotech.com Daily Mail and Mail on Sunday newspapers.